We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Saturday
May 16
10:30 - 11:30
T2
Head & neck cancer 1
Juliette Thariat, France;
Melek Tugce Yilmaz, Turkey
Mini-Orals
Clinical
10:30 - 11:30
De-intensification of postoperative radiotherapy in HNSCC by omitting contralateral elective neck irradiation– long term outcomes of the DIREKHT trial
Charlotte Frei, Germany
-239
10:30 - 11:30
Paradigm shift from bilateral elective nodal irradiation to SPECT/CT-based SNP to guide unilateral irradiation in HNSCC: multicenter prospective study
Abrahim Al-Mamgani, The Netherlands
-1232
10:30 - 11:30
Postoperative RT De-Escalation/Omission of Negative Nodal Regions in Head & Neck Squamous Cell Carcinoma: A prospective phase 2 study NCT05650034
Sara Elsharkawy , United Kingdom
-2482
10:30 - 11:30
Five-year follow-up outcomes from JCOG1208: A single-arm confirmatory trial of IMRT alone for early-stage oropharyngeal cancer
Satoaki Nakamura, Japan
-260
10:30 - 11:30
Predictors of feeding tube use and long-term dependence after curative (chemo)radiotherapy for head and neck cancer
Maiken Hjelt, Denmark
-2953
10:30 - 11:30
Long-term risk of meningioma after treatment of paediatric cancers in relation to radiation dose–volume distribution to the CNS from EBRT
Mohamed AIT-ALI, France
-3884
10:30 - 11:30
MRI-guided adaptive radiotherapy reduces xerostomia in head and neck squamous cell carcinoma patients: primary endpoint reporting of the MARTHA trial
Panagiotis Balermpas, Switzerland
-1770